Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Oct;20(4):387–391. doi: 10.1111/j.1365-2125.1985.tb05082.x

Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.

J H Silas, S Freestone, M S Lennard, L E Ramsay
PMCID: PMC1400893  PMID: 4074607

Abstract

We have compared the beta-adrenoceptor blocking and antihypertensive effects of chronic once daily treatment with conventional metoprolol 200 mg, two 'long-acting' formulations of metoprolol 200 mg and atenolol 100 mg in a cross-over study in 12 hypertensive patients concurrently receiving diuretic therapy. The peak effects of all compounds were similar, with significant reductions in exercise heart rate and blood pressure. Twenty-four hours after dosing only atenolol treatment was consistently associated with a reduction in both exercise heart rate (P less than 0.001) and blood pressure (P less than 0.02) when compared with placebo. Once daily treatment of hypertension with metoprolol, even in 'long-acting' formulations, cannot be recommended because of waning antihypertensive effect which would be missed at routine clinic attendance. Metoprolol should be prescribed twice daily in hypertension. So-called long-acting formulations do not always confer benefits over conventional dose forms.

Full text

PDF
388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bobik A., Jennings G. L., Korner P. I., Ashley P., Jackman G. Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Br J Clin Pharmacol. 1979 Jun;7(6):545–549. doi: 10.1111/j.1365-2125.1979.tb04640.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Freestone S., Silas J. H., Lennard M. S., Ramsay L. E. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing. Br J Clin Pharmacol. 1982 Nov;14(5):713–718. doi: 10.1111/j.1365-2125.1982.tb04962.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Freestone S., Silas J. H., Ramsay L. E. Sample size for short-term trials of antihypertensive drugs. Br J Clin Pharmacol. 1982 Aug;14(2):265–268. doi: 10.1111/j.1365-2125.1982.tb01971.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harron D. W., Shanks R. G. Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA). Br J Clin Pharmacol. 1981 May;11(5):518–520. doi: 10.1111/j.1365-2125.1981.tb01160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jeffers T. A., Webster J., Reid B., Petrie J. C., Barker N. P. Atenolol and metoprolol in mild hypertension. Br Med J. 1978 Nov 4;2(6147):1269–1269. doi: 10.1136/bmj.2.6147.1269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Johnsson G., Regårdh C. G., Sölvell L. Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol. Acta Pharmacol Toxicol (Copenh) 1975;36(Suppl 5):31–44. doi: 10.1111/j.1600-0773.1975.tb03320.x. [DOI] [PubMed] [Google Scholar]
  7. Karlberg B. E., Nilsson O., Tolagen K., Nitelius E., Waern U. Once-daily metoprolol in primary hypertension. Clin Pharmacol Ther. 1979 Apr;25(4):399–407. doi: 10.1002/cpt1979254399. [DOI] [PubMed] [Google Scholar]
  8. Kieso H. A., Gould B. A., Mann S., Hornung R. S., Altman D. G., Raftery E. B. Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone. Br Med J (Clin Res Ed) 1983 Sep 10;287(6394):717–720. doi: 10.1136/bmj.287.6394.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leahey W. J., Neill J. D., Varma M. P., Shanks R. G. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol. Eur J Clin Pharmacol. 1980 Jun;17(6):419–424. doi: 10.1007/BF00570158. [DOI] [PubMed] [Google Scholar]
  10. Lennard M. S., Silas J. H., Freestone S., Ramsay L. E., Tucker G. T., Woods H. F. Oxidation phenotype--a major determinant of metoprolol metabolism and response. N Engl J Med. 1982 Dec 16;307(25):1558–1560. doi: 10.1056/NEJM198212163072505. [DOI] [PubMed] [Google Scholar]
  11. Lennard M. S., Silas J. H. Rapid determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by high-performance liquid chromatography. J Chromatogr. 1983 Jan 14;272(1):205–209. doi: 10.1016/s0378-4347(00)86120-4. [DOI] [PubMed] [Google Scholar]
  12. Lennard M. S., Silas J. H., Smith A. J., Tucker G. T. Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. J Chromatogr. 1977 Mar 11;133(1):161–166. doi: 10.1016/s0021-9673(00)89216-x. [DOI] [PubMed] [Google Scholar]
  13. Mahgoub A., Idle J. R., Dring L. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of Debrisoquine in man. Lancet. 1977 Sep 17;2(8038):584–586. doi: 10.1016/s0140-6736(77)91430-1. [DOI] [PubMed] [Google Scholar]
  14. Petrie J. C., Jeffers T. A., Robb O. J., Scott A. K., Webster J. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br Med J. 1980 Jun 28;280(6231):1573–1574. doi: 10.1136/bmj.280.6231.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Quaterman C. P., Kendall M. J., Welling P. G. Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation. Eur J Clin Pharmacol. 1979 Mar 26;15(2):97–103. doi: 10.1007/BF00609871. [DOI] [PubMed] [Google Scholar]
  16. Reybrouck T., Amery A., Fagard R., Jousten P., Lijnen P., Meulepas E. Beta-blockers: once or three times a day? Br Med J. 1978 May 27;1(6124):1386–1388. doi: 10.1136/bmj.1.6124.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Scott A. K., Rigby J. W., Webster J., Hawksworth G. M., Petrie J. C., Lovell H. G. Atenolol and metoprolol once daily in hypertension. Br Med J (Clin Res Ed) 1982 May 22;284(6328):1514–1516. doi: 10.1136/bmj.284.6328.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Silas J. H., Barker A. T., Ramsay L. E. Clinical evaluation of Dinamap 845 automated blood pressure recorder. Br Heart J. 1980 Feb;43(2):202–205. doi: 10.1136/hrt.43.2.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilcox R. G., Hampton J. R. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension. Br Heart J. 1981 Nov;46(5):498–502. doi: 10.1136/hrt.46.5.498. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES